Frontlight ResearchEarly access
Metastatic breast cancer trials in United States
222 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleSTUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER)
- Where
- Lebanon
- Age
- 18 years and over
- People
- 36
- Run by
- Dartmouth-Hitchcock Medical Center
See details and how to joinNCT05716516 - No phaseTaking peopleExercise in Metastatic Breast Cancer: EMBody
- Where
- Avon, Boston, Carmel, Indianapolis, New Haven
- Age
- 18 years and over
- People
- 100
- Run by
- Indiana University
See details and how to joinNCT05468034 - Phase 2Taking peopleTamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer
- Where
- Buffalo
- Age
- 18 years and over
- People
- 30
- Run by
- Roswell Park Cancer Institute
See details and how to joinNCT06434064 - Phase 1/2Taking peopleEvexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
- Where
- Cleveland, Hershey, Hinsdale, Laredo, Loma Linda, Miami, Nashville, Newport, San Diego, Ypsilanti
- Age
- 18 years and over
- People
- 52
- Run by
- SynDevRx, Inc.
See details and how to joinNCT05455619 - Phase 2Taking peopleHigh Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer
- Where
- Atlanta
- Age
- 18 years and over
- People
- 29
- Run by
- Emory University
See details and how to joinNCT06492759 - Phase 1/2Taking peopleAbemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer
- Where
- New York
- Age
- 18 years to 90 years
- People
- 42
- Run by
- Icahn School of Medicine at Mount Sinai
See details and how to joinNCT05095207 - Phase 2Taking peopleArtificial Intelligence and Machine Learning to Guide CDK4/6 Inhibitor Rechallenge in Breast Cancer.
- Where
- La Jolla
- Age
- 18 years and over
- People
- 105
- Run by
- University of California, San Diego
See details and how to joinNCT07227233 - Phase 1/2Taking peopleOpen-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
- Where
- Atlanta, Augusta, Boston, Buffalo, Canton, Charlotte, Dallas, Detroit, Durham, Fort Wayne, Houston, Orlando, Tacoma
- Age
- 18 years and over
- People
- 150 worldwide
- Run by
- Incyclix Bio
See details and how to joinNCT05735080 - Phase 1/2Taking peoplePembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- Where
- New York
- Age
- 19 years to 90 years
- People
- 41
- Run by
- Weill Medical College of Cornell University
See details and how to joinNCT03449238 - Phase 2Taking peopleStudy of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer
- Where
- Bensalem, Columbia, Dallas, Nashville, Norfolk, Salem, San Antonio
- Age
- 18 years and over
- People
- 36
- Run by
- SCRI Development Innovations, LLC
See details and how to joinNCT05748834 - No phaseTaking peopleLiving Well With Advanced Breast Cancer
- Where
- Columbus
- Age
- 18 years and over
- People
- 50
- Run by
- Ohio State University Comprehensive Cancer Center
See details and how to joinNCT07227038 - No phaseTaking peopleA Study for CTC Expression and cfDNA/RNA Assessment in Metastatic Breast Cancer Patients
- Where
- Pittsburgh
- Age
- 18 years and over
- People
- 187
- Run by
- Menarini Silicon Biosystems, INC
See details and how to joinNCT06833853 - No phaseTaking peopleEngage Psychosocial Intervention for Cancer Symptoms
- Where
- Durham
- Age
- 18 years and over
- People
- 190
- Run by
- Duke University
See details and how to joinNCT06555588 - Phase 1/2Taking peopleA Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)
- Where
- Gainesville, Los Angeles
- Age
- 18 years to 99 years
- People
- 65
- Run by
- University of Southern California
See details and how to joinNCT04333706 - Early phase 1Taking peopleTopical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer
- Where
- Columbus
- Age
- 18 years and over
- People
- 50
- Run by
- Ohio State University Comprehensive Cancer Center
See details and how to joinNCT05417308 - Phase 2Taking peopleTart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy
- Where
- Sacramento
- Age
- 18 years and over
- People
- 86
- Run by
- University of California, Davis
See details and how to joinNCT06268665 - Phase 2Taking peopleInvestigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
- Where
- Allentown, Basking Ridge, Commack, Harrison, Hartford, Miami, Middletown, Montvale, New York, Norwalk, San Carlos, Uniondale
- Age
- 18 years and over
- People
- 145
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT03808337 - Phase 1Taking peopleA Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- Where
- Nashville
- Age
- 18 years and over
- People
- 61
- Run by
- Kind Pharmaceuticals LLC
See details and how to joinNCT05187832 - Phase 1Taking peopleSafety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer
- Where
- Atlanta, Honolulu, Houston, Lebanon, Milwaukee, New York, Norwalk
- Age
- 18 years and over
- People
- 70
- Run by
- OncoTherapy Science, Inc.
See details and how to joinNCT02926690 - Phase 2Taking peopleA Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
- Where
- Basking Ridge, Birmingham, Boston, Chapel Hill, Chicago, Commack, Harrison, Middletown, Montvale, New York, San Francisco, Uniondale
- Age
- 18 years and over
- People
- 201
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06099769 - No phaseTaking peopleCollection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer
- Where
- Rochester
- Age
- 18 years and over
- People
- 2,000
- Run by
- Mayo Clinic
See details and how to joinNCT06217874 - Phase 2Taking peopleA Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Age
- 18 years and over
- People
- 34
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT04683679 - No phaseTaking peopleHarnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
- Where
- Chapel Hill, Raleigh
- Age
- 18 years to 99 years
- People
- 500
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT03769415 - Phase 1Taking peopleX-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma
- Where
- Charlotte, Durham, Greenville, Washington D.C.
- Age
- 18 years and over
- People
- 52
- Run by
- Immunolight, LLC
See details and how to joinNCT04389281 - Phase 1Taking peopleSHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells
- Where
- Boston, New York
- Age
- 18 years and over
- People
- 24
- Run by
- General Oncology, Inc.
See details and how to joinNCT04150042